Cetuximab-induced hypertrichosis of the scalp and eyelashes.
Vano-Galvan
Sergio
S
Ríos-Buceta
Luis
L
Ma
Dong-Lai
DL
Fernández-Chacón
Concepción
C
Viera
Juan Carlos
JC
Jaén
Pedro
P
D000369:Aged, 80 and over; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy / Q000532:radiotherapy / Q000556:secondary; D000068818:Cetuximab; D066246:ErbB Receptors; D005140:Eyelashes; D006258:Head and Neck Neoplasms / Q000188:drug therapy / Q000532:radiotherapy; D006801:Humans; D006983:Hypertrichosis / Q000139:chemically induced*; D008297:Male; D012535:Scalp; D012878:Skin Neoplasms / Q000188:drug therapy / Q000532:radiotherapy / Q000556:secondary
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D066246:ErbB Receptors; D000068818:Cetuximab